Thomas Gad, CHIEF BUSINESS OFFICER at Y-mAbs Therapeutics, Inc. (YMAB), sold 95,000 shares at $12.97 ($1.3M) on 2024-09-16, disclosed to the SEC on 2024-09-17.
Seasonal sale ($1.3M) by CHIEF BUSINESS OFFICER — this insider has traded YMAB in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.47 | 65,000 | $876K | 69.2% |
| 2 | $12.97 | 30,000 | $389K | 30.8% |
| Total | $13.31 avg | 95,000 | $1.3M | 100% |
| Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |
| YMAB | SELL | 2023-12-15 | $1.0M | — | Filing → |